References
Clinical Immunology [in Russian], A. V. Karaulov (ed.), Moscow Information Agency, Moscow.
M. A. Piradov, “Guillain-Barre syndrome: diagnosis and treatment,” Nevrol. Zh., 2, 4–9 (2001).
D. R. Cornblath, A. K. Ashbury, J. W. Albers, et al., “Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathies,” Neurol., 41, 617–618 (1991).
E. M. Hol, W. H. Gispen, P. R. Bar, et al., “ACTH-related peptides: receptors and signal transduction system involved in their neurotrophic and neuroprotective actions,” Peptides, 16, No. 5, 979–993 (1995).
A. Kiss, “The hypothalamo-hypophyseal-adrenocortical axis: organization, dynamic aspects and the effect of stress on corticotrophinreleasing hormone activity in neurons,” Bratisl. Lek. Listy, 100, No. 11, 611–624 (1999).
D. J. Torpy and G. P. Chrousos, “The three-way interactions between the hypothalamic-pituitary-adrenal and gonadal axes and immune system,” Baillieres Clin. Rheumatol., 10, No. 2, 181–198 (1996).
S. Tsagarakis and A. Grossman, “Corticotropin-releasing hormone: interactions with the immune system,” Neuroimmunomodulation, 1, No. 6, 329–344 (1994).
W. P. Vandertop, W. B. de Vries, N. C. Notermans, et al., “Experimentally-induced autonomic neuropathy beneficial effect of a topical ACTH 4–9 analogue on oculomotor nerve regeneration,” Neurosurgery, 35, No. 3, 457–461 (1994).
I. M. Van Rijzingen, W. H. Gispen, B. M. Spruit, et al., “The ACTH analog ORG 2766 and recovery after brain damage in animal models – a review,” Behav. Brain Res., 74, No. 1–2, 1–15 (1996).
E. I. Webster, I. J. Elenkov, and G. P. Chrousos, “The role of Corticotropin-releasing hormone in neuroendocrine-immune interactions,” Mol. Psychiat., 2, No. 5, 368–372 (1997).
Author information
Authors and Affiliations
Additional information
Translated from Zhurnal Nevrologii i Psikhiatrii imeni S. S. Korsakova, Vol. 108, No. 7, pp. 72–73, July, 2008.
Rights and permissions
About this article
Cite this article
Ponomarev, V.V., Dashkevich, E.I. & Khodulev, V.I. Neuroendocrine Impairments in Inflammatory Demyelinating Polyneuropathies. Neurosci Behav Physi 39, 633–634 (2009). https://doi.org/10.1007/s11055-009-9186-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11055-009-9186-7